Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pazopanib in SFT and EMC
NCT02066285Phase 2Completed
- Sponsor
- Spanish Group for Research on Sarcoma
- Start
- Jun 2014
- Primary completion
- Dec 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pazopanib in solitary fibrous tumor (SFT), extraskeletal myxoid chondrosarcoma (EMC), sponsored by Spanish Group for Research on Sarcoma. Started Jun 2014; status: completed.
02
Drugs
pazopanib
03
Conditions
solitary fibrous tumor (SFT)extraskeletal myxoid chondrosarcoma (EMC)
Beyond the preview
Go deeper on NCT02066285.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02066285.